FDA Action on Antiseptic Wash Products: What is Next for the Industry?
Duration: 60 Minutes
The FDA just banned 19 active ingredients that are used in antibacterial soaps. This major regulation will have a huge impact on this multi-million-dollar industry since the FDA Rule will require companies to remove these ingredients from their products or remove the products from the market. Manufacturers will have one year to take these products off the market or reformulate them. This presentation will cover FDA Action on Antiseptic Wash Products and what is next for the Industry.
Objectives of the Presentation
Why Should you Attend
- To learn about FDA's reasons for banning certain ingredients in antiseptic/antibacterial soap products
- To identify the 19 ingredients that FDA banned from use in antiseptic soaps
- To understand why FDA deferred rulemaking for other ingredients
- To understand timelines for FDA compliance with their Final Rule
- To learn which products are not affected by the final rule and usage requirements
- To hear about the industry response to FDA's actions and what the future may hold
Attending this presentation will give one a better understanding of why FDA took this action regarding Antiseptic Wash products and how these major changes are being implemented as well as implications for the future of these products.
Who will Benefit
- FDA reasons for banning certain ingredients in antiseptic/antibacterial soap products
- 19 ingredients that FDA says can no longer be marketed in antiseptic soaps
- Ingredients for which FDA has deferred rulemaking to allow for development and submission of new safety and effectiveness data
- Timelines for compliance with FDA's final rule
- Products not affected by the final rule and usage requirements
- Industry response to FDA's actions on Antiseptic Soaps
- Regulatory managers
- Regulatory associates
- Antiseptic product marketing managers
- QA Managers